|Day's Range||56.65 - 57.60|
|52 Week Range||24.85 - 59.50|
|PE Ratio (TTM)||23.18|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In 1Q17, the Advisory Board earned a major part of its healthcare business revenues from consultancy services, but it expects to see higher demand for health tech.
In 1Q17, the Advisory Board (ABCO) reported adjusted EBITDA of ~$45 million, which was higher than its guidance of $37 million–$42 million.
In 1Q17, the Advisory Board (ABCO) reported revenues of ~$194.1 million, which was higher than its guidance of $185 million–$190 million but ~0.7% lower YoY.